Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease

Sponsor
Aristotle University Of Thessaloniki (Other)
Overall Status
Completed
CT.gov ID
NCT03566537
Collaborator
(none)
73
1
31
2.4

Study Details

Study Description

Brief Summary

To detect any changes in Quality of Life in patients with benign thyroid diseases who undergo thyroidectomy compared to patients with benign thyroid diseases and conservative treatment and healthy subjects.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Thyroidectomy

Detailed Description

Benign thyroid diseases are a common public health problem. It has been reported that thyroid diseases can affect Quality of Life (QoL), but this is not easy to be assessed. Therefore, a valid instrument is necessary. Such an instrument is Thyroid-related patient-reported outcomes questionnaire (ThyPRO). ThyPRO has been recently translated and validated in Greek language. The questionnaire consists of 85 items grouped in 14 scales concerning goiter, hypothyroidism, hyperthyroidism and eye symptoms, tiredness, cognitive impairment, anxiety, depression, emotional susceptibility, cosmetic complaints and impaired social, and daily and sex life, as well as overall quality of life.

A few studies have demonstrated that various thyroid therapies may improve some aspects of QoL. The aim of the present study is to address the impact of thyroidectomy in QoL in patients with benign thyroid diseases.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
73 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease
Actual Study Start Date :
Jun 11, 2018
Actual Primary Completion Date :
Jun 11, 2020
Actual Study Completion Date :
Jan 11, 2021

Arms and Interventions

Arm Intervention/Treatment
Cases

Patients who are going to undergo a thyroid surgery due to symptomatic non-toxic multinodular goiter, uncontrolled thyrotoxicosis or suspicious FNA

Procedure: Thyroidectomy
Thyroidectomy

Controls

Patients with benign thyroid disease, not undergoing thyroidectomy

Outcome Measures

Primary Outcome Measures

  1. Alterations in Quality of Life after thyroidectomy for benign thyroid disease [2 years]

    To detect any changes in Quality of Life in patients with benign thyroid diseases who undergo thyroidectomy compared to patients with benign thyroid diseases and conservative treatment. The Greek, cross-cultural validated, version of ThyPRO questionnaire will be used, as it comprises a reliable and validated instrument to measure thyroid-related quality of life. The 84 questions of ThyPRO are categorized in 13 scales that involve: goiter, hypothyroidism, hyperthyroidism and eyes symptoms, tiredness, cognitive impairment, anxiety, depressivity, emotional susceptibility, cosmetic complaints and impaired social, and daily and sex life. The scales are all scored and the final scores were transformed to a scale from 0 to 100. Lower scores reflect a better thyroid-related quality of life, whereas higher scores reflect a worse quality of life.

Secondary Outcome Measures

  1. Correlation of alterations in Quality of Life after thyroidectomy for benign thyroid disease with secondary characteristics of the patients [2 years]

    Correlation of alterations in Quality of Life after thyroidectomy for benign thyroid disease with secondary characteristics of the patients ( eg age, thyroid autoimmunity, thyroid function, Vitamin D levels)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  1. Patient is over 18 years old

  2. Patient scheduled for a non-emergency operation

  3. Patient diagnosed with benign thyroid disease

Exclusion Criteria:
  1. Patient is participating in another clinical trial which may affect this study's outcomes

  2. Patient with thyroid cancer

  3. Previous operation at the thyroid and parathyroid glands or neck irradiation

  4. Patient unable to read and write in Greek

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ahepa Hospital ThessalonĂ­ki Central Macedonia Greece 54453

Sponsors and Collaborators

  • Aristotle University Of Thessaloniki

Investigators

  • Principal Investigator: Theodosios Papavramidis, Asst. Prof., Aristotle University Of Thessaloniki

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Papavramidis Theodossis, Assistant Professor of surgery, Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT03566537
Other Study ID Numbers:
  • 26181
First Posted:
Jun 25, 2018
Last Update Posted:
Apr 27, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2021